Solventum, an American healthcare company spun off from 3M in 2024, has completed the sale of its purification and filtration business to Thermo Fisher Scientific for approximately USD 4 billion in cash, subject to customary adjustments, effective 1 September 2025.
The divested business is a leading global provider of purification and filtration technologies used in the production of biologics, as well as in medical technologies and industrial applications. It operates worldwide, with sites across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific region.
Paksoy is pleased to announce that a team led by partner Stéphanie Beghe Sönmez and associates Meriç Saçak Albaş and Cansın Taner acted as Turkish counsel to Solventum, alongside Cleary Gottlieb Steen & Hamilton, which served as global counsel on this multijurisdictional transaction.
Share
Related persons
You can contact us for detailed information.


Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
6 March 2026
Paksoy advises on Türkiye Petrolleri’s landmark USD 4 billion Sukuk Programme and inaugural USD 1 billion issuance
Paksoy is pleased to have advised on the establishment of Türkiye Petrolleri’s USD 4 billion Sukuk Issuance Programme and the successful…
27 February 2026
International Women’s Day 2026 – Women at Paksoy
At Paksoy, we believe women are fundamental to our leadership and value creation. Their contribution is not just part of our identity - it…
23 February 2026
Doğuhan Uygun and Pınar Noberi contributed to the Austrian Yearbook on International Arbitration 2026
We are pleased to announce that Doğuhan Uygun, partner, and Pınar Noberi, associate, have contributed to the Austrian Yearbook on…
18 February 2026
Once again, we are recognised among the top-tier in the Chambers Global Guide 2026
We are appreciative of the continued top-tier recognition of our firm and lawyers by the Chambers Global Guide 2026.
16 February 2026
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage
Paksoy advised H.I.G. Capital on its acquisition of Atlas Dunnage.
12 February 2026
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey
Paksoy advised Tiryaki Agro on its acquisition of Savola Foods Turkey.
